| Product ID | 81013-105_dbc83501-9402-2a8d-e053-2a95a90a45c5 |
| NDC | 81013-105 |
| Product Type | Human Otc Drug |
| Proprietary Name | Aspire Mucus and Pain Relief Softgels |
| Generic Name | Aspire Mucus And Pain Relief Softgels |
| Dosage Form | Capsule, Liquid Filled |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-04-14 |
| Marketing Category | OTC MONOGRAPH FINAL / |
| Application Number | part341 |
| Labeler Name | Aspire Pharmaceuticals Inc. |
| Substance Name | ACETAMINOPHEN; GUAIFENESIN |
| Active Ingredient Strength | 325 mg/1; mg/1 |
| Pharm Classes | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |